Survival benefit with proapoptotic molecular and pathologic responses from dual targeting of mammalian target of rapamycin and epidermal growth factor receptor in a preclinical model of pancreatic neuroendocrine carcinogenesis.

Source:http://linkedlifedata.com/resource/pubmed/id/20823411

J. Clin. Oncol. 2010 Oct 10 28 29 4425-33

Download in:

View as

General Info

PMID
20823411